sales@jinjingroup.com

  News Introduction

Vinpocetine(CAS 42971-09-5) and other drugs comprehensive treatment of SHL

Date : 2016/10/12 11:41:17

First Affiliated Hospital of Zhengzhou University of Otolaryngology researchers published papers to evaluate the sudden deafness (SHL) treatment and efficacy. Studies have shown that the use of intratympanic infusion of dexamethasone treatment plus ganglioside, vinpocetine(CAS 42971-09-5) and other drugs comprehensive treatment of SHL, a significant effect. The article published in 2013 07, "Journal of Clinical Otorhinolaryngology Head and Neck Surgery".

Ninety patients with SHL were randomly divided into two groups: basic medicine group and combined treatment group. The patients in the basic medicine group were treated with nerve ganglioside and vasodilator, and the combined treatment group (n = 57) Ears) with intratympanic infusion of dexamethasone plus basic drug group drug treatment.

The total effective rate (73.53%) of the combination therapy group was much higher than that of the basic drug group (37.78%), the curative effect was significant (P <0.05).